November, 09 2010, 02:56pm EDT

Obama Administration Denies Endangered Species Act Protection to 251 Species
Imperiled Plants and Animals Relegated to "Candidate" List Where They'll Languish for Years Without Protection
WASHINGTON
The Obama administration
today denied Endangered Species Act protection to 251 plants and
animals that government scientists have said need those protections
to avoid extinction. Instead, the administration has placed them
indefinitely on a list of "candidate" species, where many have
already languished for years without help.
"The Obama administration has no sense of
urgency when it comes to protecting imperiled plants and animals,"
said Kieran Suckling, executive director of the Center for
Biological Diversity. "With extinction looming, imperiled species
need more than promises of hope and change. They need real
protection, and they need it now."
So far, the U.S. Fish and Wildlife
Service under the Obama administration has provided Endangered
Species Act protection to just 51 plants and animals, and only one
of those occurs in the continental United States. By comparison, the
Clinton administration protected 522 species; the George H.W. Bush
administration protected 231. The average annual rate for the Obama
administration is 26, while for the Clinton administration it was 65
and for the first Bush administration it was 58.
"The Obama administration has been
abysmal when it comes to protecting our most vulnerable plants and
animals," Suckling said. "The Endangered Species Act can save these
251 species, but only if they are granted protection."
Many of the "candidate" species have been
waiting for protection for decades, including the white fringeless
orchid, which has been on the waiting list for 30 years, and the
eastern massasauga rattlesnake, which has been a candidate for 25
years.
Delays have real consequences. At least
24 species have gone extinct after being designated a candidate for
protection, including the Louisiana prairie vole, Tacoma pocket
gopher, San Gabriel Mountains blue butterfly, Sangre de Cristo
peaclam from New Mexico and numerous Hawaiian invertebrates.
The Center and other groups have an
active lawsuit in Washington, D.C., showing that continued delays in
protecting the 251 candidate species is illegal because the U.S.
Fish and Wildlife Service is not making expeditious progress listing
species as required by the Endangered Species Act.
Background on the Candidate Species
The 251 candidates include a wide variety
of species, from shorebirds such as the red knot, which migrates
along the Atlantic Coast during one of the longest migrations in the
animal world, to the aboriginal pricklyapple, a cactus found in
Florida, to the Pacific fisher, a relative of the mink and otter
that is dependent on old-growth forests on the West Coast. Being
designated as a candidate does not provide any formal protection to
the 251 species, a number of which have been waiting for protection
for almost as long as the Endangered Species Act has existed. On
average, the candidates have been waiting 20 years for
protection.
The current review includes five new
species since the last review: the Kentucky arrow darter, a fish in
danger of extinction due to surface coal mining and gas exploration
in eastern Kentucky; the Rosemont talus snail, a highly endangered
snail that occurs only in the footprint of a proposed copper mine
outside Tucson, Ariz.; the Kenk's amphipod, a crustacean threatened
by urban sprawl around Washington, D.C.; Packard's milk vetch, a
plant in Idaho threatened by off-road vehicle use and invasive
plants; and the Vandenberg monkeyflower, a plant threatened by
development in Santa Barbara, Calif. One species, the Palm Springs
round-tailed ground squirrel, was removed from the candidate list
due to the development of a Habitat Conservation Plan.
Each of the candidates are given a
priority number ranging from 1 to 12 based on their taxonomic rank
(e.g. species, subspecies or population) and magnitude and immediacy
of threats, with lower numbers indicating higher priority. The
majority of candidates are rated as either priority 2 or 3, meaning
they are in immediate danger of extinction.
The following are but a few examples of
the candidate species:
Oregon spotted frog -
The Oregon spotted frog has been waiting for protection since 1991.
It is found in California, Oregon, Washington and British Columbia
in wetlands from sea level to at least 5,500 feet. The frog's
habitat has been lost at an accelerating pace, and the species is
now absent from up to 90 percent of its former range, including all
of California.
Sonoyta mud turtle - The
Sonoyta mud turtle has been a candidate since 1997. In the United
States, it has been reduced to a single reservoir in Arizona that is
isolated from populations in Mexico. The turtle eats insects,
crustaceans, snails, fish, frogs and plants. Females bury their eggs
on land.
Florida semaphore cactus
- The Florida semaphore cactus has been waiting for protection
for six years. It is a large prickly pear cactus from the Florida
Keys that was thought to have been driven extinct by cactus
collectors and road construction in the late 1970s, but was
rediscovered in the mid-1980s. Much of its historic habitat has
fallen prey to development, destruction and fragmentation. Just two
populations remain.
Eastern massasauga - The
eastern massasauga is a wetland rattlesnake of the Midwest and Great
Lakes, and has been found in Illinois, Indiana, Iowa, Michigan,
Minnesota, Missouri, New York, Ohio, Pennsylvania and Ontario,
Canada. It has been waiting for protection for 25 years, having been
made a candidate in 1982. The snake is extirpated from 40 percent of
the counties it historically inhabited due to wetland losses from
urban and suburban sprawl, golf courses, mining and
agriculture.
Parachute beardtongue - The
Parachute beardtongue, also known as the Parachute penstemon, is an
attractive perennial plant that grows on rocky cliffs above the
Colorado River near the town of Parachute, Colo. It occupies just
two locations of less than one-third of a square mile. The
beardtongue has been listed as a candidate for protection under the
Endangered Species Act since 1990. Both populations are on lands
slated for oil-shale mining.
White fringeless orchid -
The white fringeless orchid is a two-foot-tall herb that grows
in wetlands in the Blue Ridge Mountains and Alabama's coastal plain.
It has been found in Alabama, Georgia, Tennessee, Kentucky and South
Carolina, and has been a candidate for 30 years. The orchid is
limited to 53 locations.
At the Center for Biological Diversity, we believe that the welfare of human beings is deeply linked to nature — to the existence in our world of a vast diversity of wild animals and plants. Because diversity has intrinsic value, and because its loss impoverishes society, we work to secure a future for all species, great and small, hovering on the brink of extinction. We do so through science, law and creative media, with a focus on protecting the lands, waters and climate that species need to survive.
(520) 623-5252LATEST NEWS
Dems Demand Answers as Trump Photo Disappears From DOJ Online Epstein Files
"What else is being covered up?"
Dec 20, 2025
Congressional Democrats on Saturday pressed US Attorney General Pam Bondi for answers regarding the apparent removal of a photo showing President Donald Trump surrounded by young female models from Friday's Department of Justice release of files related to the late convicted child sex criminal Jeffrey Epstein.
Amid the heavily redacted documents in Friday's DOJ release was a photo of a desk with an open drawer containing multiple photos of Trump, including one of him with Epstein and convicted child sex trafficker Ghislaine Maxwell and another of him with the models.
However, the photo—labeled EFTA00000468 in the DOJ's Epstein Library—was no longer on the site as of Saturday morning.
"This photo, file 468, from the Epstein files that includes Donald Trump, has apparently now been removed from the DOJ release," Democrats on the House Oversight Committee noted in a Bluesky post. "AG Bondi, is this true? What else is being covered up? We need transparency for the American public."
This photo, file 468, from the Epstein files that includes Donald Trump has apparently now been removed from the DOJ release.AG Bondi, is this true? What else is being covered up? We need transparency for the American public.
[image or embed]
— Oversight Dems (@oversightdemocrats.house.gov) December 20, 2025 at 9:30 AM
Numerous critics have accused the Trump administration of a cover-up due to the DOJ's failure to meet a Friday deadline to release all Epstein-related documents and heavy redactions—including documents of 100 pages or more that are completely blacked out—to many of the files.
Deputy Attorney General Todd Blanche responded to the criticism by claiming that "the only redactions being applied to the documents are those required by law—full stop."
"Consistent with the statute and applicable laws, we are not redacting the names of individuals or politicians unless they are a victim," he added.
Earlier this year, officials at the Federal Bureau of Investigation reportedly redacted Trump's name from its file on Epstein, who was the president's longtime former friend and who died in 2019 in a New York City jail cell under mysterious circumstances officially called suicide while facing federal child sex trafficking and conspiracy charges.
Trump has not been accused of any crimes in connection with Epstein.
House Oversight Committee Ranking Member Robert Garcia (D-Calif.) said during a Friday CNN interview that the DOJ only released about 10% of the full Epstein files.
The DOJ is breaking the law by not releasing the full Epstein files. This is not transparency. This is just more coverup by Donald Trump and Pam Bondi. They need to release all the files, NOW.
[image or embed]
— Congressman Robert Garcia (@robertgarcia.house.gov) December 19, 2025 at 5:06 PM
"The DOJ has had months and hundreds of agents to put these files together, and yet entire documents are redacted—from the first word to the last," Garcia said on X. "What are they hiding? The American public deserves transparency. Release all the files now!"
In a joint statement Friday, Garcia and House Judiciary Committee Ranking Member Jamie Raskin (D-Md.) said, "We are now examining all legal options in the face of this violation of federal law."
"The survivors of this nightmare deserve justice, the co-conspirators must be held accountable, and the American people deserve complete transparency from DOJ," they added.
Rep. Ro Khanna (D-Calif.)—who along with Rep. Thomas Massie (R-Ky.) introduced the Epstein Files Transparency Act, which was signed into law by Trump last month and required the release of all Epstein materials by December 19—said in a video published after Friday's document dump that he and Massie "are exploring all options" to hold administration officials accountable.
"It can be the impeachment of people at Justice, inherent contempt, or referring for prosecution those who are obstructing justice," he added.
Keep ReadingShow Less
Israeli Forces Massacre 6 Palestinians Celebrating Wedding at Gaza School Shelter
"This isn't a truce, it's a bloodbath," said a relative of some of the victims, who included women, an infant, and a teenage girl.
Dec 20, 2025
Funerals were held Saturday in northern Gaza for six people, including children, massacred the previous day by Israeli tank fire during a wedding celebration at a school sheltering displaced people, as the number of Palestinians killed during the tenuous 10-week ceasefire rose to over 400.
On Friday, an Israel Defense Forces (IDF) tank blasted the second floor of the Gaza Martyrs School, which was housing Palestinians displaced by the two-year war on Gaza in the al-Tuffah neighborhood of Gaza City.
Al Jazeera and other news outlets reported that the attack occurred while people were celebrating a wedding.
Al-Shifa Hospital director Mohammed Abou Salmiya said those slain included a 4-month-old infant, a 14-year-old girl, and two women. At least five others were injured in the attack.
"It was a safe area and a safe school and suddenly... they began firing shells without warning, targeting women, children and civilians," Abdullah Al-Nader—who lost relatives including 4-month-old Ahmed Al-Nader in the attack—told Agence France-Presse.
Witnesses said IDF troops subsequently blocked first responders including ambulances and civil defense personnel from reaching the site for over two hours.
"We gathered the remains of children, elderly, infants, women, and young people," Nafiz al-Nader, another relative of the infant and others killed in Friday's attack, told reporters. "Unfortunately, we called the ambulance and the civil defense, but they couldn't get by the Israeli army."
The IDF said that “during operational activity in the area of the Yellow Line in the northern Gaza Strip, a number of suspicious individuals were identified in command structures," and that "troops fired at the suspicious individuals to eliminate the threat."
The Yellow Line is a demarcation boundary between areas of Gaza under active Israeli occupation—more than half of the strip's territory, including most agricultural and strategic lands—and those under the control of Hamas.
"The claim of casualties in the area is familiar; the incident is under investigation," the IDF said, adding that it "regrets any harm to uninvolved parties and acts as much as possible to minimize harm to them."
Since the October 7, 2023 Hamas-led attack on Israel, more than 250,000 Palestinians have been killed or wounded by Israeli forces, including approximately 9,500 people who are missing and presumed dead and buried beneath rubble. Classified IDF documents suggest that more than 80% of the Palestinians killed by Israeli forces were civilians.
Around 2 million Palestinians have also been displaced—on average, six times—starved, or sickened in the strip.
Gaza officials say at least 401 Palestinians have been killed since a US-brokered ceasefire between Israel and Hamas took effect on October 10. Gaza's Government Media Office says Israel has violated the ceasefire at least 738 times.
"This isn't a truce, it's a bloodbath," Nafiz al-Nader told Agence France-Presse outside al-Shifa Hospital on Saturday.
Israel says Hamas broke the truce at least 32 times, with three IDF soldiers killed during the ceasefire.
Israeli Prime Minister Benjamin Netanyahu and Yoav Gallant, his former defense minister, are fugitives from the International Criminal Court in The Hague, where they are wanted for alleged war crimes and crimes against humanity in Gaza, including murder and forced starvation.
Israel is also facing a genocide case filed by South Africa at the International Court of Justice, also in The Hague. A United Nations commission, world leaders, Israeli and international human rights groups, jurists, and scholars from around the world have called Israel's war on Gaza a genocide.
Friday's massacre came as Steve Witkoff, President Donald Trump's Mideast envoy, other senior US officials, and representatives of Egypt, Qatar, Turkey, and the United Arab Emirates met in Miami to discuss the second phase of Trump's peace plan, which includes the deployment of an international stabilization force, disarming Hamas, the withdrawal of IDF troops from the strip, and the establishment of a new government there.
Keep ReadingShow Less
Trump's 9 New Prescription Drug Deals 'No Substitute' for Systemic Reform
"Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices," said one campaigner.
Dec 19, 2025
"Starting next year, American drug prices will come down fast and furious and will soon be the lowest in the developed world," President Donald Trump claimed Friday as the White House announced agreements with nine pharmaceutical manufacturers.
The administration struck most favored nation (MFN) pricing deals with Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi. The president—who has launched the related TrumpRx.gov—previously reached agreements with AstraZeneca, EMD Serono, Eli Lilly, Novo Nordisk, and Pfizer.
"The White House said it has made MFN deals with 14 of the 17 biggest drug manufacturers in the world," CBS News noted Friday. "The three drugmakers that were not part of the announcement are AbbVie, Johnson & Johnson, and Regeneron, but the president said that deals involving the remaining three could be announced at another time."
However, as Trump and congressional Republicans move to kick millions of Americans off of Medicaid and potentially leave millions more uninsured because they can't afford skyrocketing premiums for Affordable Care Act (ACA) plans, some critics suggested that the new drug deals with Big Pharma are far from enough.
"When 47% of Americans are concerned they won't be able to afford a healthcare cost next year, steps to reduce drug prices for patients are welcomed, especially by patients who rely on one of the overpriced essential medicines named in today's announcement," said Merith Basey, CEO of Patients for Affordable Drugs Now, in a statement.
"But voluntary agreements with drug companies—especially when key details remain undisclosed—are no substitute for durable, system-wide reforms," Basey stressed. "Patients are overwhelmingly calling on Congress to do more to lower prescription drug prices by holding Big Pharma accountable and addressing the root causes of high drug prices, because drugs don't work if people can't afford them."
As the New York Times reported Friday:
Drugs that will be made available in this way include Amgen's Repatha, for lowering cholesterol, at $239 a month; GSK's asthma inhaler, Advair Diskus, at $89 a month; and Merck's diabetes medication Januvia, at $100 a month.
Many of these drugs are nearing the end of their patent protection, meaning that the arrival of low-cost generic competition would soon have prompted manufacturers to lower their prices.
In other cases, the direct-buy offerings are very expensive and out of reach for most Americans.
For example, Gilead will offer Epclusa, a three-month regimen of pills that cures hepatitis C, for $2,492 a month on the site. Most patients pay far less using insurance or with help from patient assistance programs. Gilead says on its website that "typically a person taking Epclusa pays between $0 and $5 per month" with commercial insurance or Medicare.
While medication prices are a concern for Americans who face rising costs for everything from groceries to utility bills, the outcome of the ongoing battle on Capitol Hill over ACA tax credits—which are set to expire at the end of the year—is expected to determine how many people can even afford to buy health insurance for next year.
The ACA subsidies fight—which Republicans in the US House of Representatives ignored in the bill they passed this week before leaving Capitol Hill early—has renewed calls for transitioning the United States from its current for-profit healthcare system to Medicare for All.
"At the heart of our healthcare crisis is one simple truth: Corporations have too much power over our lives," Rep. Pramila Jayapal (D-Wash.), former chair of the Congressional Progressive Caucus, said on social media Friday. "Medicare for All is how we take our power back and build a system that puts people over profits."
Jayapal reintroduced the Medicare for All Act in April with Rep. Debbie Dingell (D-Mich.) and Senate Health, Education, Labor, and Pensions Committee Ranking Member Bernie Sanders (I-Vt.). The senator said Friday that some of his top priorities in 2026 will be campaign finance reform, income and wealth inequality, the rapid deployment of artificial intelligence, and Medicare for All.
Earlier this month, another backer of that bill, US Sen. Chris Van Hollen (D-Md.), said: "We must stop tinkering around the edges of a broken healthcare system. Yes, let's extend the ACA tax credits to prevent a huge spike in healthcare costs for millions. Then, let's finally create a system that puts your health over corporate profits. We need Medicare for All."
It's not just progressives in Congress demanding that kind of transformation. According to Data for Progress polling results released late last month, 65% of likely US voters—including 78% of Democrats, 71% of Independents, and 49% of Republicans—either strongly or somewhat support "creating a national health insurance program, sometimes called 'Medicare for All.'"
Keep ReadingShow Less
Most Popular


